Author Archives: Özge Özkaya, PhD

Questionnaire for Pulmonary Arterial Hypertension Patients to Help Determine Quality of Life

Researchers from the U.S., Germany, Switzerland, and the U.K. have developed a new questionnaire, to help assess symptoms of pulmonary arterial hypertension (PAH) and the disease’s impact on patients’ lives. The questionnaire, called PAH-SYMPACT, was created following guidance from the U.S. Food and Drug Administration (FDA) to include patient reported outcomes…